Furthermore, MYC translocations are a poor prognostic factor in DLBCL in association with BCL2 and/or BCL6 translocations, and MYC re-arrangements are also a driver of high-grade transformation in follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) [43]. This evidence concerns the gene MYC and follicular lymphoma.